Senator Rand Paul, M.D., on FDA Modernization
Congress directed $12.5 million to the FDA for Fiscal Year 2023, including $5 million to launch “a comprehensive strategy for new alternative methods for product testing” dubbed the New Alternatives Methods Program. This new effort is a step forward, the United States should use a larger portion of existing resources for alternative development. More effective screening methods will allow billions spent on drug development to be used more effectively.
The Center for a Humane Economy noted that FDA, the pharmaceutical sector, and academic institutions involved in research all have pledged to abide by the “3 Rs” when it comes to animal testing — reduction, refinement, and replacement of animal tests. These key stakeholders all must act with urgency to embrace a better, safer, more reliable safety regimen.
www.animalwellnessaction.org
www.centerforahumaneeconomy.org
Facebook: / animalwellnessaction
Facebook: / centerforahumaneeconomy
Instagram: / animalwellnessaction
Instagram: / centerforahumaneeconomy
Twitter: / awaction_news
Twitter: / thehumanecenter